FDA Drug Recalls

Recalls / Class II

Class IID-0554-2022

Product

DBI Magnums Tablet (Caffeine 200 mg) 100 and 500 count & 3 and 36 count packets & Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-941-00

Affected lot / code info
Product Codes: M941L M940LA Bulk Lots: 19C065, 19F081, 19H083, 17D088

Why it was recalled

CGMP Deviations

Recalling firm

Firm
ULTRAtab Laboratories, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
50 Toc Dr, N/A, Highland, New York 12528-1506

Distribution

Quantity
8,727,657 tablets
Distribution pattern
Bulk product was distributed to 3 distributors who may have distributed finished product.

Timeline

Recall initiated
2022-01-26
FDA classified
2022-02-09
Posted by FDA
2022-02-16
Terminated
2025-01-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0554-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls